Your session is about to expire
← Back to Search
Use of Virtual Technology for Procedural Anxiety
N/A
Waitlist Available
Led By Samuel Rodriguez, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of procedure (usually no more than 2-4 hours)
Awards & highlights
Study Summary
This trial will test if VR/AR headsets can help reduce a kid's anxiety and pain during minor procedures like lumbar punctures or cardiac catheterization, compared to no technology distraction.
Eligible Conditions
- Procedural Anxiety
- Anxiety
- Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ duration of procedure (usually no more than 2-4 hours)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of procedure (usually no more than 2-4 hours)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Measure anxiety score
Secondary outcome measures
Asses cumulative medication dosing and the duration of procedure
Evaluation of Passive vs Active Interventions
Parent and Child Satisfaction Questionnaire
+1 moreOther outcome measures
Fear assessment
Pain Assessment
Procedural Compliance
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Cardiac Cathertization PatientsExperimental Treatment1 Intervention
Participants will use technology based distraction during procedure.
Group II: Allergy PatientsExperimental Treatment1 Intervention
Participants will use technology based distraction during procedure
Group III: Procedure-Only PatientsActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Use of Virtual Technology
2018
N/A
~60
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,400 Previous Clinical Trials
17,341,771 Total Patients Enrolled
Samuel Rodriguez, MDPrincipal InvestigatorStanford University
2 Previous Clinical Trials
511 Total Patients Enrolled
Thomas J Caruso, MD, MEdPrincipal InvestigatorStanford University
1 Previous Clinical Trials
111 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently experiencing nausea.You have a history of seizures.You have experienced severe motion sickness in the past.You have issues with your vision.You or your parents prefer to be under general anesthesia during the trial.You have significant problems with your memory, thinking, or decision-making abilities.
Research Study Groups:
This trial has the following groups:- Group 1: Allergy Patients
- Group 2: Procedure-Only Patients
- Group 3: Cardiac Cathertization Patients
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Can individuals still join this study at this juncture?
"As per the information posted on clinicaltrials.gov, this medical trial is not actively enrolling patients at present. Initially listed on June 1st 2018 and amended lastly in July of 2022, there are other 941 studies that currently require volunteers to participate."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger